We make a start with the situation of the US oil market. On Friday, the release of the US Baker Hughes total rig count, ...
Biotech stock Halozyme Therapeutics is climbing back in constructive form from a severe drop in November. Shares got a boost after the drug-delivery developer reiterated its 2024 forecast and raised ...